Hikma Pharmaceutical | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Almirall EUR 1.49B 1.81M 2024-12
argenx SE 4.26B 3.84B 2024-09
AstraZeneca USD 41.04B 168M 2025-03
Autolus Therapeutics Ltd 371.11M 56.22M 2025-03
Bayer EUR 32.58B 537M 2025-03
Fresenius EUR 19.41B 135M 2025-03
Galapagos EUR 2.75B 149.05M 2025-03
Genmab DKK 5.3B 31.4B 2025-03
GlaxoSmithKline GBP 14.16B 486M 2025-03
GRIFOLS EUR 5.64B 244.27M 2025-03
Hikma Pharmaceutical USD 2.29B 88M 2024-06
Lonza CHF 9.33B 23M 2024-12
Merck EUR 29.99B 1.66B 2024-12
Orion EUR 1.07B 61.8M 2025-03
Recordati EUR 1.98B 100.9M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 74.07B 3.78B 2025-03
UCB EUR 10.03B 1.08B 2024-12



Hikma Pharmaceutical Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.